Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $38.0200 (-3.36%) ($37.6500 - $40.6600) on Fri. Mar. 16, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.78% (three month average) | RSI | 53 | Latest Price | $38.0200(-3.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.9% a day on average for past five trading days. | Weekly Trend | EDIT advances 4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(63%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.39% in a week (0% probabilities). VIXM(-13%) TLT(-5%) SHY(-5%) GDXJ(-5%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.39% (StdDev 4.78%) | Hourly BBV | 0 () | Intraday Trend | -4.5% | | | |
|
Resistance Level | $38.43 | 5 Day Moving Average | $40.41(-5.91%) | 10 Day Moving Average | $40.81(-6.84%) | 20 Day Moving Average | $38.43(-1.07%) | To recent high | -13.7% | To recent low | 54.7% | Market Cap | $2.361b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |